What is BLSM's current stock price?

BLSM (BlossomHill Therapeutics, Inc.) is currently trading at $16.38 with a market cap of $476.3M.

What sector is BlossomHill Therapeutics, Inc. in?

BlossomHill Therapeutics, Inc. (BLSM) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

BLSM BlossomHill Therapeutics, Inc.

NASDAQHealthcare

$16.38+1.24%ClosedMarket Cap: $476.3M

As of 2026-08-17

Why BLSM matters now

BlossomHill Therapeutics, Inc. (BLSM) is a US stock in Healthcare. The latest InvestLog snapshot shows $16.38 with +1.24% on the session and $476.3M in market capitalization.

The latest indexable market news headline is "BlossomHill Therapeutics (NASDAQ:BLSM) Director Bihua Chen Purchases 312,500 Shares of Stock" from Defense World.

Latest News

BlossomHill Therapeutics (NASDAQ:BLSM) Director Bihua Chen Purchases 312,500 Shares of StockDefense World · 2026-08-11

BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public OfferingGlobeNewsWire · 2026-08-06

BlossomHill Therapeutics Aims For $125 Million IPO On Cancer Treatment Pipeline PromiseSeeking Alpha · 2026-08-05

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

0.00

Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.